Vaccination-to-case ratio was lower for Black and Hispanic versus White men during full analytic period<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, April 14, 2023 (HealthDay News) — Most racial and ethnic-minority groups had a higher incidence of mpox than non-Hispanic White men, according to research published in the April 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/em>.<\/p>\n Krishna Kiran Kota, Ph.D., from the CDC Mpox Emergency Response Team, and colleagues calculated rate ratios (RRs) for incidence and vaccination rates and vaccination-to-case ratios in men aged 18 years and older to examine racial and ethnic disparities in mpox incidence and vaccination rates.<\/p>\n The researchers found that in all racial and ethnic-minority groups except non-Hispanic Asian men, incidence was higher than among non-Hispanic White men. Incidence was higher among non-Hispanic Black or African and Hispanic or Latino men than among White men at the peak of the outbreak (August 2022; RRs, 6.9 and 4.1, respectively). Vaccination rates were higher among racial and ethnic-minority groups than among White men. However, Black and Hispanic men had lower vaccination-to-case ratios than White men during the full analytic period (8.8 and 16.2, respectively, versus 42.5). <\/p>\n “These findings illustrate the potential impact of and continued need for equity-based vaccination strategies, such as community-specific tailored messaging and expansion of vaccination services to reach racial and ethnic minority groups,” the authors write.<\/p>\n